| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $714.0M | $668.2M | $619.7M |
| YoY Revenue Growth % | +6.9% | +7.8% | — |
| Gross Profit | $447.3M | $409.3M | — |
| Gross Margin % | 62.7% | 61.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $97.6M | $51.1M | -$155.0M |
| Operating Margin % | 13.7% | 7.6% | -25.0% |
| Net Income (GAAP) | $144.6M | $22.8M | -$159.2M |
| EBITDA (Normalized) | $154.0M | $77.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $236.2M | $235.2M | $214.4M |
| Capital Expenditures (CapEx) | $70.5M | $32.8M | — |
| Free Cash Flow (FCF) | $165.6M | $202.4M | $214.4M |
| FCF Margin % | 23.2% | 30.3% | 34.6% |
| Return on Invested Capital (ROIC %) | 10.8% | 4.8% | — |
| Cash & Short-Term Equivalents | $553.4M | $483.2M | — |
| Total Debt (Short + Long Term) | $347.7M | $550.1M | — |
| Total Stockholders' Equity | $922.4M | $768.2M | — |